Moderna announced on Friday it expects to produce 20 million doses of its experimental coronavirus vaccine by the end of the year, Reuters reports.
The company continues to expect to make 500 million to 1 billion doses of the vaccine in 2021, Moderna said in a filing with the US securities regulator.
(Arutz Sheva’s North American desk is keeping you updated until the start of Rosh Hashanah in New York. The time posted automatically on all Arutz Sheva articles, however, is Israeli time.)
Read more